Welcome to our dedicated page for UNITED STATES ANTIMONY SEC filings (Ticker: UAMY), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on UNITED STATES ANTIMONY's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into UNITED STATES ANTIMONY's regulatory disclosures and financial reporting.
United States Antimony Corporation reported lower sales and a swing to loss while significantly strengthening its balance sheet and advancing growth projects for the six months ended June 30, 2026. Revenue was $14,709,670, down from $17,525,128 a year earlier, with antimony sales declining and zeolite sales increasing. Cost inflation and sharply higher operating expenses, including $7,738,892 of share-based compensation, drove an operating loss of $14,498,095 versus prior-year operating income of $377,999. The company recorded a net loss of $11,184,200 compared with net income of $728,079 in 2025.
Liquidity improved through equity issuance and a federal grant. Cash and cash equivalents were $41,434,379 and total assets $190,616,714, while debt remained low at $334,775. An at-the-market stock program raised $49,070,838 net, and a $27.0 million Defense Production Act grant is funding expansion of the Thompson Falls, Montana facility, of which $12,848,246 has been recognized as a reduction of property, plant and equipment. The smelter expansion, with total estimated capital of about $39 million, was substantially completed in the quarter. The company also holds a $43,219,151 equity stake in Larvotto Resources Limited, generating significant unrealized gains, and secured a five-year IDIQ contract with the U.S. Defense Logistics Agency with a maximum value of $245 million, with initial shipments of approximately 82,000 pounds of antimony to be recognized as $2.6 million of third-quarter revenue.
State Street Corporation and its affiliate SSGA Funds Management, Inc. reported beneficial ownership of common stock of United States Antimony Corp as of June 30, 2026. State Street, together with related investment adviser entities, reported beneficial ownership of 11,339,710 shares, representing 7.7% of the common stock.
These shares are held with 0 sole voting or dispositive power and shared authority over voting for 11,093,238 shares and shared dispositive power over 11,339,710 shares. Separately, SSGA Funds Management, Inc. reported beneficial ownership of 8,570,410 shares, or 5.8% of the class, all with shared voting and dispositive power. The securities are held across multiple SSGA and State Street advisory entities for their clients.
United States Antimony Corporation scheduled the release of its financial and operating results for the second quarter and six months ended June 30, 2026, after U.S. markets close on Tuesday, August 11, 2026. A conference call and webcast will follow that day at 4:15 p.m. Eastern time.
The company provided webcast and dial-in details, including a toll-free and international number plus an access code, and stated that a replay will be available on its investor website. It also outlined its operations in antimony, zeolite, and precious metals and noted prior acquisitions of mining claims and properties in Alaska, Montana, and Ontario beginning in 2024.
UNITED STATES ANTIMONY CORP director Jon R. Marinelli bought shares in the company. On the reported date, he made an open-market purchase of 12,500 shares of Common Stock at a weighted average price of $7.45 per share.
After this transaction, Marinelli directly owned 12,500 shares. According to the filing, the shares were purchased in multiple trades at prices ranging from $7.41 to $7.50 per share.
United States Antimony Corporation reported results from its 2026 Annual Shareholders Meeting held on June 12, 2026. The company stated that each proposal received the requisite votes for approval. Director nominees drew strong support, with Lloyd Joseph Bardswich receiving 48,579,499 votes for and minimal abstentions. Other nominees, including Gary C. Evans, John M. Keane, and others, were also elected with large majorities. Two additional proposals each obtained substantial "for" votes, including one with 73,504,344 votes in favor, confirming overall shareholder support for the company’s agenda.
United States Antimony Corporation reported a change in its outside auditor driven by a firm acquisition. On June 3, 2026, Assure CPA, LLC was acquired by Sadler Gibb & Associates, LLC, and Assure effectively resigned as the company’s independent registered public accounting firm.
The Audit Committee and full Board approved engaging Sadler Gibb as the new independent registered public accounting firm for the fiscal year ending December 31, 2026. Assure’s audit reports on the 2025 and 2024 financial statements contained no adverse opinions, disclaimers, or qualifications.
The company states there were no disagreements or reportable events with Assure through June 3, 2026. The lead engagement partner and professional staff who handled prior audits have moved to Sadler Gibb, providing continuity for future audits.
UNITED STATES ANTIMONY CORP senior vice president and chief financial officer Richard R. Isaak reported a disposition of 100,000 shares of common stock back to the company. This was a "Disposition to issuer" at $9.75 per share. After this transaction, he directly holds 344,376 common shares, indicating he retains a substantial equity position.
US Antimony filed Form 144 notices reporting proposed and recent sales of Common Stock. The filing lists a proposed sale entry showing 100,000 shares with an associated figure 975,000 and an effective date of 06/02/2026. It also lists a restricted lot of 120,179 shares dated 03/24/2025. Recent sales in the past three months include 30,000 shares on 03/25/2026 and 53,334 shares on 03/26/2026 with proceeds of $477,872.64.
UNITED STATES ANTIMONY CORP Interim CFO Shawn P. Winkler has filed an initial Form 3 reporting his status as an officer of the company. The filing shows no reported purchases, sales, gifts, or derivative exercises, and lists no current derivative positions or holding entries.
United States Antimony Corporation used its latest update to outline a mixed first quarter of 2026 and an aggressive growth plan. Sales were $6.8 million, roughly in line with last year’s $7 million, but the company reported a net loss of $11.3 million, driven mainly by $4.8 million of non-cash stock compensation, a $4.1 million unrealized loss on Larvotto equity, and higher costs tied to ramping operations.
Management emphasized a strong balance sheet, with $60.2 million in cash, U.S. Treasuries, and equity securities at quarter-end, plus $12.8 million received afterward from a $27 million U.S. government expansion grant and $48.6 million of equity proceeds. Inventory rose to $22 million as the company builds feedstock for higher antimony production.
The call focused heavily on growth initiatives: expanding the Thompson Falls smelter toward roughly 230 tons per month of new capacity, ramping Mexican and Bolivian antimony supply, and preparing a hydrometallurgical plant in Idaho targeting 1,000 tons per month of 99.9% pure antimony by 2028. The company is also advancing tungsten at the Fostung deposit in Canada, where an inferred resource of 14.62 million tonnes grading 0.17% WO3 was cited, and a Nolan Creek antimony-gold project in Alaska with previously reported high-grade resources.
In zeolites, the BRZ division launched a cattle nutrition segment and reported record shipment tonnage in March and April, with March about 60% higher than the prior year and both months exceeding internal targets by over 40% and 60%, respectively. Management reiterated 2026 revenue guidance of $125 million, expecting $75 million to $95 million of that from antimony ingot deliveries under U.S. government contracts, supported by existing inventory, new mine plans, and expanding processing capacity.